News Archive

• Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs

  November 8, 2023

  CIRM-Funded Programs to Receive Access to Avid’s Suite of World-Class CGT CDMO Services to Support Clinical Development Activities TUSTIN, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract […]

  Read more

• Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility

  October 17, 2023

  Newly Launched CGMP Manufacturing Suites Undergoing Final Environmental Monitoring and Performance Qualification with Grand Opening Planned for January 2024 Completion of CGT Facility Brings Company’s Total Revenue Generating Capacity to up […]

  Read more

• Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference

  September 26, 2023

  TUSTIN, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services […]

  Read more

• Avid Bioservices to Participate in RBC Capital Markets Global Healthcare Conference

  May 10, 2023

  TUSTIN, Calif., May 10, 2023 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services […]

  Read more

• Avid Bioservices Unveils Completed Mammalian Cell Facilities Expansion Providing Significantly Increased Capacity for Existing and Future Customers

  April 4, 2023

  Company to Host Open House to Celebrate Official Launch of Newest CGMP Mammalian Cell Manufacturing Suites within Myford Facility First Customer Project in Newly Expanded Capacity to Kick-Off This Month Company […]

  Read more

• Avid Bioservices Appoints Oksana Lukash as Vice President, People

  November 16, 2022

  TUSTIN, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services […]

  Read more

• Avid Bioservices to Participate in the Credit Suisse 31st Annual Healthcare Conference

  November 2, 2022

  TUSTIN, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services […]

  Read more

• Avid Bioservices to Participate in RBC Global CDMO Conference

  September 27, 2022

  TUSTIN, Calif., Sept. 27, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services […]

  Read more

• Avid Bioservices Appoints Michael Alston, Jr. as Vice President, Operations

  September 22, 2022

  Accomplished Operations Professional Promoted from Role as Director of Project Engineering; Credited with Leading All of the Company’s Ongoing Facility Expansion Projects TUSTIN, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), […]

  Read more

• Avid Bioservices to Participate in Morgan Stanley 20th Annual Global Healthcare Conference

  September 7, 2022

  TUSTIN, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services […]

  Read more


< View Latest News